JENISE SANTOS: Open Payments
NPI 1760966535 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 113 payments from 15 companies in 2025. Trend: 2023 $159 · 2024 $1,827 · 2025 $2,598
Food & beverage: $2,496Education: $102
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 21 | $519 |
| ABBVIE INC. | 23 | $404 |
| Regeneron Healthcare Solutions, Inc. | 11 | $295 |
| GENZYME CORPORATION | 8 | $263 |
| Novartis Pharmaceuticals Corporation | 10 | $175 |
| Galderma Laboratories, L.P. | 13 | $173 |
| Amgen Inc. | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 5 | $121 |
| LEO Pharma Inc. | 6 | $115 |
| Lilly USA, LLC | 4 | $114 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, OTEZLA, RINVOQ, Sotyktu, TALTZ.
Industry payments across GA — which companies pay providers there.
